# Are GLP-1 Drugs Prescribed Off-Label? What the Records Show | Buy This GLP

What prescribing records from PCOS, childbirth, and youth studies reveal about GLP-1 use and why a missing diabetes code cannot establish off-label use.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/are-glp1-drugs-prescribed-off-label
Updated: 2026-11-14
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Are GLP-1 Drugs Prescribed Off-Label? What the Records Show

Prescriptions rose after PCOS diagnosis, around childbirth, and among young people. The records cannot show which prescriptions were off-label.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20269 min readUpdated November 2026

Started within a year of PCOS diagnosis · 0.14% · 5.97% · 2018 · 2024 · Only 11.5% of those women had coded type 2 diabetes. · The chart shows the two reported endpoints.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   In one Polish healthcare network, initiation within a year of a PCOS diagnosis rose from 0.14% in 2018 to 5.97% in 2024.
-   Only 11.5% of incretin users in that cohort had a recorded type 2 diabetes diagnosis. The study could not establish the intended use of each prescription.
-   Prescribing studies around childbirth and among young people also show increased use, including use for weight management.

The term off-label describes an approved drug used outside its approved labeling [\[4\]](https://buythisglp.com/research/are-glp1-drugs-prescribed-off-label#ref-4). The product, intended use and patient population all matter. A missing diabetes diagnosis alone cannot tell you whether a prescription was off-label. Some products are approved for weight management.

## Prescribing after a PCOS diagnosis

Studies of [GLP-1 treatment and PCOS](https://buythisglp.com/research/do-glp1-drugs-help-pcos) ask a different question from the studies that count prescriptions. In one Polish private network, 5.97% of women diagnosed with PCOS in 2024 started an incretin drug within a year, up from 0.14% in 2018. Each later calendar year was associated with higher odds of starting treatment (adjusted odds ratio 1.64, 95% CI 1.56–1.73) [\[1\]](https://buythisglp.com/research/are-glp1-drugs-prescribed-off-label#ref-1).

Across the cohort, 11.5% of incretin users had coded type 2 diabetes and 75.5% also had a record of metformin exposure. Incretin users had a higher median BMI than women who took only metformin or received neither treatment. These records describe prescribing patterns and cannot establish effects on ovulation, fertility or other PCOS outcomes [\[1\]](https://buythisglp.com/research/are-glp1-drugs-prescribed-off-label#ref-1).

## Use around childbirth and among young people

A U.S. study found that prescribing in the year after delivery rose from 0.3 to 14.6 per 1,000 deliveries between 2019 and 2024. The year before delivery includes time before pregnancy, so prescriptions recorded during that window cannot all be attributed to use in pregnancy [\[2\]](https://buythisglp.com/research/are-glp1-drugs-prescribed-off-label#ref-2).

Danish registry data showed 418 new users per 100,000 people aged 12 to 24 in 2025, up from 8.4 in 2018. The study attributed much of the growth to semaglutide for weight management. To study [how long people stay on a GLP-1](https://buythisglp.com/research/how-long-do-people-stay-on-a-glp1), the researchers measured how long prescriptions covered patients. They found that 38% still had coverage after a year, but the records could not explain why people stopped[\[3\]](https://buythisglp.com/research/are-glp1-drugs-prescribed-off-label#ref-3).

Coverage depends on your plan

The [GLP-1 insurance guide](https://buythisglp.com/research/does-insurance-cover-glp1) explains how to check which product and indication your plan covers before filling a prescription.

## Frequently asked

What does off-label prescribing mean?

It means prescribing an approved drug in a way its approved labeling does not cover, such as for a different condition or patient population.

Does a missing diabetes diagnosis make a GLP-1 prescription off-label?

A diabetes diagnosis code alone cannot answer that. Some products are approved for weight management, and these data did not establish the indication for each prescription.

## Sources

1.  \[1\] Dziewierz A, Kulicka N, Stolarska K, Ahmatovic A, Domienik-Karłowicz J (2026). Temporal Trends and Clinical Characteristics of Incretin-Based Therapy Use in Women With Polycystic Ovary Syndrome: A Real-World Cohort Study From a Polish Private Healthcare Network Diabetes, Obesity & Metabolism. [PMID 42297761](https://pubmed.ncbi.nlm.nih.gov/42297761/)
2.  \[2\] Lessard C, Cary C, In A, Steinle J, et al. (2026). Prescribing Trends in Glucagon-Like Peptide-1 Medications Among Pregnant and Postpartum Persons Obstetrics and Gynecology. [PMID 41505759](https://pubmed.ncbi.nlm.nih.gov/41505759/)
3.  \[3\] Kildegaard H, Andersen JH, Vinding RK, Kloppenborg JT, Pottegård A (2026). Use of Glucagon-Like Peptide-1 Receptor Agonists in Danish Adolescents and Young Adults 2018-2025 Obesity (Silver Spring, Md.). [PMID 42252120](https://pubmed.ncbi.nlm.nih.gov/42252120/)
4.  \[4\] U.S. Food and Drug Administration (2018). Understanding Unapproved Use of Approved Drugs Off Label FDA. [Source](https://www.fda.gov/understanding-unapproved-use-approved-drugs-label)

## Where to get it

### GLP-1 telehealth prescribers

The sellers whose own pricing describes an ongoing prescribed plan, rather than a checkout that assumes you already have a script.

[See the board →](https://buythisglp.com/best/flat-dose-pricing)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
